SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,537,000 | -6.0% | 106,899 | -0.5% | 0.06% | -8.8% |
Q1 2019 | $3,764,000 | +5.4% | 107,424 | -0.1% | 0.07% | -4.2% |
Q4 2018 | $3,571,000 | -52.7% | 107,509 | -28.2% | 0.07% | -40.8% |
Q3 2018 | $7,542,000 | -15.6% | 149,785 | +0.3% | 0.12% | -20.0% |
Q2 2018 | $8,939,000 | -14.0% | 149,360 | -34.2% | 0.15% | -15.7% |
Q1 2018 | $10,396,000 | +5.4% | 226,980 | -8.3% | 0.18% | +6.0% |
Q4 2017 | $9,867,000 | -7.4% | 247,605 | -7.0% | 0.17% | -9.7% |
Q3 2017 | $10,651,000 | -26.6% | 266,265 | -20.9% | 0.19% | -26.8% |
Q2 2017 | $14,515,000 | +15.2% | 336,765 | -16.3% | 0.25% | +13.4% |
Q1 2017 | $12,596,000 | +24.0% | 402,435 | 0.0% | 0.22% | +17.9% |
Q4 2016 | $10,161,000 | -45.8% | 402,435 | -47.0% | 0.19% | -43.6% |
Q3 2016 | $18,763,000 | +10.0% | 758,705 | -9.4% | 0.34% | +9.1% |
Q2 2016 | $17,052,000 | +43.2% | 837,125 | +7.2% | 0.31% | +50.7% |
Q1 2016 | $11,906,000 | -28.9% | 780,715 | -37.3% | 0.20% | -25.2% |
Q4 2015 | $16,735,000 | +43.2% | 1,245,170 | +49.5% | 0.27% | +47.3% |
Q3 2015 | $11,685,000 | – | 832,890 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |